| Literature DB >> 26462433 |
Jeffrey E Noland1, Jonathan E Breitenbach2, Holly J R Popham3, Sue M Hum-Musser4, Heiko Vogel5, Richard O Musser6.
Abstract
The Helicoverpa zea transcriptome was analyzed 24 h after H. zea larvae fed on artificial diet laced with Helicoverpa zea single nucleopolyhedrovirus (HzSNPV). Significant differential regulation of 1,139 putative genes (p < 0.05 T-test with Benjamini and Hochberg False Discovery Rate) was detected in the gut epithelial tissue; where 63% of these genes were down-regulated and 37% of genes were up-regulated compared to the mock-infected control. Genes that play important roles in digestive physiology were noted as being generally down-regulated. Among these were aminopeptidases, trypsin-like serine proteases, lipases, esterases and serine proteases. Genes related to the immune response reacted in a complex nature having peptidoglycan binding and viral antigen recognition proteins and antiviral pathway systems down-regulated, whereas antimicrobial peptides and prophenoloxidase were up-regulated. In general, detoxification genes, specifically cytochrome P450 and glutathione S-transferase were down-regulated as a result of infection. This report offers the first comparative transcriptomic study of H. zea compared to HzSNPV infected H. zea and provides further groundwork that will lead to a larger understanding of transcriptional perturbations associated with viral infection and the host response to the viral insult in what is likely the most heavily infected tissue in the insect.Entities:
Keywords: Helicoverpa zea; HzSNPV; gut epithelium; microarray
Year: 2013 PMID: 26462433 PMCID: PMC4553479 DOI: 10.3390/insects4030506
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 2.769
Primers designed to verify gene regulation in the gut epithelium.
| Gene Identifier 1 | Gene Name | Forward Primer | Reverse Primer |
|---|---|---|---|
| AAL34109.1 | Alpha-amylase | 5'-accgttggcgtcaaatctac-3' | 5'-ggagctgctgtagtggtcgt-3' |
| AAT08964.1 | Cytochrome P450 (CYP) | 5'-gttggatcccattcagtgct-3' | 5'-ctggctcttgagatgctggt-3' |
| EEB16964.1 | Glucose Dehydrogenase (GDH) | 5'-tgactgtccaagactggtg-3' | 5'-atcgctccgctctttctccta-3' |
| AAZ52554.1 | Prophenoloxidase Subunit 2 (PROPO) | 5'-gcctaccagttgttcgttat-3' | 5'-agggtactttctgtccttcag-3' |
| AAO16241.1 | Effector Caspase (ECAS) | 5'-caagccagagaacctgtggt-3' | 5'-gaagcagaaggtgagccatc-3' |
| ACL51928.1 | Lysozyme (LYZ) | 5'-atgagttgaggaggcaagga-3' | 5'-gcccactttgtctgtcttcc-3' |
| ACD74811.1 | Eukaryotic Initiation Factor 5c | 5'-agaggttcgtcgagtggcta-3' | 5'-agcctcactggctgctctta-3' |
1 Gene identifiers correspond to the reference numbers specified by microarray analysis.
Figure 1Global gene expression profile of the gut epithelium of Helicoverpa zea infected with HzSNPV. Percentages shown in the pie chart represent the percent of genes altered in each group out of the 1,138 genes altered in this study.
Figure 2Number of genes stimulated or repressed due to viral infection associated with specific gene groups. Groups shown were most affected 24 h post infection in the gut epithelium.
Identified genes from the gut epithelium infected with HzSNPV pertaining to apoptosis, detoxification, and immunity with fold change and NCBI reference sequence indicated. The data listed represents the significant (Benjamini-Hochberg corrected t-test, p < 0.05) fold change in gene expression.
| Gene classification/name | Fold change | Gene Identifier |
|---|---|---|
|
| ||
| Caspase short class | −1.97 | XP_320581.3 |
| CG10641-PA | 2.41 | XP_624640.1 |
| Daxx-like protein | 2.67 | XP_973237.1 |
| Death related ced-3/Nedd2-like protein; Initiator caspase | −1.92 | NP_001108337.1 |
| Death related ced-3/Nedd2-like protein; Initiator caspase | −1.65 | NP_001108337.1 |
| Death related ced-3/Nedd2-like protein; Initiator caspase | −1.35 | NP_001108337.1 |
| Death related ced-3/Nedd2-like protein; Initiator caspase | −1.24 | NP_001108337.1 |
| Effector caspase; SI-caspase-1 | −2.57 | AAO16241.1 |
| Survivin | −1.86 | XP_001662572.1 |
|
| ||
| Cytochrome P450 | −8.26 | XP_0010604810.1 |
| Cytochrome P450 | −6.82 | XP_0010604810.1 |
| Cytochrome P450 | −3.59 | XP_0010604810.1 |
| Cytochrome P450 | −16.09 | NP_001104007.1 |
| Cytochrome P450 | −11.02 | NP_001104007.1 |
| Cytochrome P450 CYP4S1 | −6.88 | ABU88427.1 |
| Cytochrome P450 monooxygenase | −5.41 | NP_001104007.1 |
| GA10313-PA | 3.22 | XP_001601512.1 |
| Glutathione S-transferase | 3.39 | AAL23839.1 |
| Glutathione S-transferase | −9.38 | ABU88426.1 |
| Glutathione S-transferase GSTX01 | −11.14 | ABK29516.1 |
| Glutathione S-transferase 1 | −8.69 | P46430.1 |
|
| ||
| Adhesion-like transmembrane protein | 2.61 | CAB65413.1 |
| | 2.49 | AAX51193.1 |
| Hemolymph proteinase 18 | 4.41 | AAZ52554.1 |
| M-like protein | 5.07 | YP_313517.1 |
| Prophenoloxidase subunit 2 | 5.46 | ABF18489.1 |
| Toll-interacting protein | 1.66 | XP_975168.1 |
Figure 3Relative fold changes (y-axis) in expression of alpha-amylase (AAM), cytochrome P450 (CYP), effector caspase (ECAS), glucose dehydrogenase (GDH), lysozyme (LYZ), and prophenoloxidase (PROPO). These data indicate the relationship between these genes and the fold change expressed between mock and virus infected treatments.